OTLC
PINK Oncotelic Therapeutics Inc$0.0210 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0210, and at the day’s high of $0.0250
- YTD change
- -73.21%
- vs 20-day SMA
- -21.85%
- vs 200-day SMA
- -55.72%
Price ranges
Price & Performance
-0.02 (-46.84%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 94.2% away from all-time highs of $0.3600
- OTLC is down 73% since the beginning of the year
- OTLC is down 70% over the past 12 months
- OTLC is down 41% over the past 1 month
- 0% of all OTLC investors are betting against OTLC
OTLC reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -72.0%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0005
- Last 5 days
- -17.39%
- vs 8-day SMA
- -12.64%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
